
What is the PFA Summit?
The 'PFA Summit: From Bench to Bedside' offers a unique full-day deep dive into this innovation’s trajectory—bridging foundational biophysics, emerging device engineering, and the practical realities of contemporary EP workflows.
This Summit aims to:
- Illuminate the scientific principles and selective cellular mechanisms of PFA
- Showcase engineering breakthroughs in catheter and waveform design
- Analyse pivotal trials and early clinical implementation
- Debate regulatory and educational hurdles for broader adoption
- Explore PFA’s transformative potential for AF ablation and other arrhythmias
Whether you're an electrophysiologist, biomedical engineer, healthcare policymaker, or industry innovator—this is your opportunity to engage with the pulse of the future.
“The world of PFA is evolving so rapidly that we felt compelled to offer a structured, high-impact journey—covering biophysical foundations, device technologies, and the most current clinical insights.” - Prof. Serge Boveda & Dr. Atul Verma - PFA Summit Directors
The PFA Summit will take place on Saturday, 11 April from 8:30 to 17:30 at the Palais des Congres - Porte Maillot, level 3.
The EHRA PFA Summit 2026 is a co-organised initiative of:
- The European Heart Rhythm Association (EHRA), a branch of the ESC
- The Canadian Heart Rhythm Society (CHRS)
The Summit programme will be submitted to UEMS for accreditation.
How to register
Registration is open to all EHRA delegates. Registration is proposed as an add-on event to your EHRA Congress registration and is open on a first-come first-served basis.
PFA Summit registration includes:
- Access to all sessions during the full-day conference event
- Permanent coffee break & finger food lunch
- Video on demand until 27 April 2026
Registration fees
Registration terms and conditions
Scientific programme
The EHRA PFA Summit 2026 will be divided into two parts, designed to build upon each other:
Part 1 – Morning Session: Technology & Foundations
- The science and selectivity of electroporation
- Comparative overview of PFA devices and waveforms
- Technical innovations in catheter design
- Mapping integration and procedure workflows
Session 1: The Basics of Pulsed Field Ablation
Chairs: D Miklavčič, A Verma, S Boveda
8:30 Covering the basics of Pulsed Field Ablation – electroporation of cell membrane - L Rems
8:45 Tissue response to Pulsed Field Ablation – pulse delivery - A Ivorra
9:00 Tissue Selectivity of Pulsed Field Ablation – how selective is it? – K Neven
9:15 Q&A Panel – 20 min
Session 2: Applying basics to clinical application
Chairs: D Miklavčič, A Verma, S Boveda
9:50 Choosing the right waveform and catheter – D Miklavčič
10:05 Predicting the lesion size – B Kos
10:20 Understanding/Managing PFA Problems – A Verma
10:35 Q&A Panel – 20 min
Session 3: Pulsed Field Ablation in the future
Chairs: D Miklavčič, A Verma, S Boveda
11:10 Learning from the others – other biomedical applications (cancer) – J Gehl
11:25 Defining endpoints in Pulsed Field Ablation – M Terricabras
11:40 Future directions for Pulsed Field Ablation – J Koruth
11:55 Q&A Panel - 20 min
Part 2 – Afternoon Session: Clinical Evidence & Application
- Latest results from pivotal trials and registries
- Real-world experience: successes and challenges
Session 1: Bridging pulsed field ablation evidence and action: what do the latest clinical trials mean for practice?
Chairs: A Sultan, J Andrade
13:15 BEAT-AF: an insider's view - P Jaïs
13:23 Understanding single-shot champion: Insights from post-hoc analyses - Tobbias Reichlin
13:31 FACIL-AF trial: French contributions to pulsed field ablation - P Defaye
13:39 Pulsed field ablation and regulatory trials: navigating investigational device exemption and global approval pathways - A Anic
13:47 What do global registries tell us? lessons from the real life - V Reddy
13:55 Round Table: clinical pulsed field ablation
Session 2: Pulsed Field Ablation in the lab: Lessons from the front lines
Chairs: D Nair, J Chun
14:30 Beyond pulmonary vein isolation: is pulsed field ablation the game-changer for adjunctive strategies? - S Tzeis
14:38 Mapping in pulsed field ablation: when is it essential and when is it not? - P Sommer
14:46 Pulsed field ablation in redo procedures: durability, failures, and long-term data - C Tondo
14:54 Ventricular pulsed field ablation: a new frontier - P Peichl
15:02 Conscious sedation or general anaesthesia for pulsed field ablation? practical evidence and workflow -
J Garcia Bolao
15:10 Combining pulsed field ablation with left atrial appendage closure: a safe and strategic approach? - O Wazni
15:18 Round table: pulsed field ablation in the lab
Session 3: Live cases: cutting-edge pulsed field ablation!
Chairs: J Vogler, D Gupta
Facilitator: D Scherr
15:45 Live case transmission from hospital: atrial fibrillation ablation and close - B Schmidt
16:00 Live case transmission from hospital:: ventricle pulsed field ablation - A Sarkozy
16:15 Live-in-the-Box: mapping pulmonary vein isolation - J OscaAsensi
16:25 Live-in-the-Box: mapping left atrium - JP Albenque
16:35 Live-in-the-Box: dual energy pulmonary vein isolation - T De Potter
Session 4: Latest science pulsed field ablation
Chairs: I Deisenhofer, D Della Rocca
*Please note that this programme may still be subject to changes.
Our mission: To reduce the burden of cardiovascular disease.